Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2010

01-10-2010 | Brief Report

Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation

Authors: A. Lasa, T. Ramón y Cajal, G. Llort, J. Suela, J. C. Cigudosa, M. Cornet, C. Alonso, A. Barnadas, M. Baiget

Published in: Breast Cancer Research and Treatment | Issue 3/2010

Login to get access

Abstract

Mutations in BRCA1 and BRCA2 genes confer a high risk of breast and ovarian cancer but the incomplete penetrance of these mutations suggests that other genetic and/or environmental factors may modify this risk. We present a family where all affected members carried a mutation in the BRCA1 gene and the index case had suffered from cancer twice in the last 27 years, whereas her monozygotic twin sister, also a carrier of the mutation, remained healthy. As copy number variants (CNVs) contribute to phenotypic diversity, a comparative genomic hybridization array (CGH) was performed to see whether the differences in the CNV profile were a modifier factor of the phenotype in our monozygotic twins. Our results show that differences in the CNVs profile were not the cause of the extremely variable penetrance observed in our MZ twin. The search for an explanation should not therefore be limited to genetic changes at the level of the DNA sequence.
Literature
1.
go back to reference Collaborative Group in Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389–1399CrossRef Collaborative Group in Hormonal Factors in Breast Cancer (2001) Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291):1389–1399CrossRef
2.
go back to reference Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66–71CrossRefPubMed Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66–71CrossRefPubMed
3.
go back to reference Wooster R, Bignell G, Lancaster J, Swift S, Seal S et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789–792CrossRefPubMed Wooster R, Bignell G, Lancaster J, Swift S, Seal S et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789–792CrossRefPubMed
4.
go back to reference Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130CrossRefPubMed Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130CrossRefPubMed
5.
go back to reference Begg CB, Haile RW, Borg A, Malone KE, Concannon P et al (2008) Variation of breast cancer risk among BRCA1/2 carriers. JAMA 299(2):194–201CrossRefPubMed Begg CB, Haile RW, Borg A, Malone KE, Concannon P et al (2008) Variation of breast cancer risk among BRCA1/2 carriers. JAMA 299(2):194–201CrossRefPubMed
6.
go back to reference Milne RL, Osorio A, Cajal TR, Vega A, Llort G et al (2008) The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 14(9):2861–2869CrossRefPubMed Milne RL, Osorio A, Cajal TR, Vega A, Llort G et al (2008) The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 14(9):2861–2869CrossRefPubMed
7.
go back to reference Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM et al (2006) A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 45(7):646–655CrossRefPubMed Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM et al (2006) A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer 45(7):646–655CrossRefPubMed
8.
go back to reference Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31(1):33–36CrossRefPubMed Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31(1):33–36CrossRefPubMed
9.
go back to reference Rahman N, Seal S, Thompson D, Kelly P, Renwick A et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39(2):165–167CrossRefPubMed Rahman N, Seal S, Thompson D, Kelly P, Renwick A et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39(2):165–167CrossRefPubMed
10.
go back to reference Renwick A, Thompson D, Seal S, Kelly P, Chagtai T et al (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38(8):873–875CrossRefPubMed Renwick A, Thompson D, Seal S, Kelly P, Chagtai T et al (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38(8):873–875CrossRefPubMed
11.
go back to reference Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31(1):55–59CrossRefPubMed Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31(1):55–59CrossRefPubMed
12.
go back to reference Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M et al (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39(7):870–874CrossRefPubMed Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M et al (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39(7):870–874CrossRefPubMed
13.
go back to reference Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087–1093CrossRefPubMed Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087–1093CrossRefPubMed
14.
go back to reference Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 98(8):535–544CrossRefPubMed Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 98(8):535–544CrossRefPubMed
15.
go back to reference Mitchell G, Antoniou AC, Warren R, Peock S, Brown J (2006) Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 66(3):1866–1872CrossRefPubMed Mitchell G, Antoniou AC, Warren R, Peock S, Brown J (2006) Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 66(3):1866–1872CrossRefPubMed
16.
go back to reference Milne RL, Osorio A, Ramón y Cajal T, Baiget M, Lasa A et al (2010) Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 119(1):221–232CrossRefPubMed Milne RL, Osorio A, Ramón y Cajal T, Baiget M, Lasa A et al (2010) Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat 119(1):221–232CrossRefPubMed
17.
go back to reference Diez O, Brunet J, Sanz J, del Rio E, Alonso MC, Baiget M (1997) Differences in phenotypic expression of a new BRCA1 mutation in identical twins. Lancet 350(9079):713 Diez O, Brunet J, Sanz J, del Rio E, Alonso MC, Baiget M (1997) Differences in phenotypic expression of a new BRCA1 mutation in identical twins. Lancet 350(9079):713
18.
go back to reference Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK et al (2004) Detection of large-scale variation in the human genome. Nat Genet 36(9):949–951CrossRefPubMed Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK et al (2004) Detection of large-scale variation in the human genome. Nat Genet 36(9):949–951CrossRefPubMed
19.
go back to reference Itsara A, Cooper GM, Baker C, Girirajan S, Li J et al (2009) Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet 84(2):148–161CrossRefPubMed Itsara A, Cooper GM, Baker C, Girirajan S, Li J et al (2009) Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet 84(2):148–161CrossRefPubMed
20.
go back to reference Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH et al (2006) Global variation in copy number in the human genome. Nature 444(7118):444–454CrossRefPubMed Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH et al (2006) Global variation in copy number in the human genome. Nature 444(7118):444–454CrossRefPubMed
21.
go back to reference Bruder CE, Piotrowski A, Gijsbers AA, Andersson R, Erickson S et al (2008) Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet 82(3):763–771CrossRefPubMed Bruder CE, Piotrowski A, Gijsbers AA, Andersson R, Erickson S et al (2008) Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet 82(3):763–771CrossRefPubMed
22.
go back to reference Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215CrossRefPubMed Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215CrossRefPubMed
23.
go back to reference Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J et al (2000) Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–84CrossRefPubMed Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J et al (2000) Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–84CrossRefPubMed
24.
go back to reference Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25(43):5898–5905CrossRefPubMed Antoniou AC, Easton DF (2006) Models of genetic susceptibility to breast cancer. Oncogene 25(43):5898–5905CrossRefPubMed
25.
go back to reference Humpherys D, Eggan K, Akutsu H, Hochedlinger K, Rideout WM et al (2001) Epigenetic instability in ES cells and cloned mice. Science 293:95–97CrossRefPubMed Humpherys D, Eggan K, Akutsu H, Hochedlinger K, Rideout WM et al (2001) Epigenetic instability in ES cells and cloned mice. Science 293:95–97CrossRefPubMed
26.
go back to reference Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F et al (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102(30):10604–10609CrossRefPubMed Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F et al (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102(30):10604–10609CrossRefPubMed
27.
go back to reference Singh SM, Murphy B, O’Reilly R (2002) Monozygotic twins with chromosome 22q11 deletion and discordant phenotypes: updates with an epigenetic hypothesis. J Med Genet 39(11):e71CrossRefPubMed Singh SM, Murphy B, O’Reilly R (2002) Monozygotic twins with chromosome 22q11 deletion and discordant phenotypes: updates with an epigenetic hypothesis. J Med Genet 39(11):e71CrossRefPubMed
Metadata
Title
Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation
Authors
A. Lasa
T. Ramón y Cajal
G. Llort
J. Suela
J. C. Cigudosa
M. Cornet
C. Alonso
A. Barnadas
M. Baiget
Publication date
01-10-2010
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-0877-0

Other articles of this Issue 3/2010

Breast Cancer Research and Treatment 3/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine